SK Innovation Co. Ltd.

04/30/2024 | Press release | Distributed by Public on 04/29/2024 20:47

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)
※ The following are interim figures, and may be different from final data.
1. Details of business performance in KRW mn, %
Category Current term Previous term Changes over previous term(%) Same term of last year Changes over same term of last year (%)
('24 1Q) ('23 4Q) ('23 1Q)
Sales Current 18,855,139 19,529,300 -3.45% 19,142,879 -1.50%
Cumulative 18,855,139 77,288,486 - 19,142,879 -1.50%
Operating income Current 624,736 72,619 +760.29% 374,992 +66.60%
Cumulative 624,736 1,903,886 - 374,992 +66.60%
Net income from continuing operation before income tax Current 18,172 -52,552 Turned to
Profit
156,318 -88.37%
Cumulative 18,172 932,185 - 156,318 -88.37%
Net income Current -97,623 -2,325 -4098.84% -51,954 -87.90%
Cumulative -97,623 554,894 - -51,954 -87.90%
Net income attributable to shareholders of parent company Current -72,603 -81,771 +11.21% -131,137 +44.64%
Cumulative -72,603 256,250 - -131,137 +44.64%
- - - - - -
2. Details of information release Information provider SK innovation IR Team
Information recipients Investors & Analysts
Date & time of information release 10AM on April 29th, 2024 (KST)
Title and place of event held 1Q 2024 Earnings Conference Call
3. Contact points (department/phone number) IR Team / +82-2-2121-5114
4. Other matters to be factored into investment decisions
1. The above results are based on K-IFRS consolidated financial statements.

2. Without external audit completed, this document has been made for convenience of investors. Financial results for '24 1Q are subject to change according to the outside independent auditors' audit.

3. The presentation material will be available on the company's IR website.
(www.skinnovation.com/eng/)
※ Related disclosure 2024-04-16 Organization of Investor Relations Event